Not enough is known about MCAS. However, it may be one of the more important medical findings of our time. In a follow up interview, Dr. Matthew Hamilton shares that there are many theories about the basic mechanisms of MCA that may contribute to GI symptoms. This is especially important for dysautonomia patients who have also been diagnosed with MCAS.
In this video Dr. Guzman discusses Ehlers Danlos Syndrome (EDS), POTS and Mast Cell Activation Syndrome (MCAS), three coexisting conditions that are sometimes seen together in a segment of the POTS population.
In this video Dr. Peltier discusses POTS and other disorders commonly associated with POTS including small fiber neuropathies, Sjogren syndrome, B12 deficiency, mast cell disorders and others.
In this video, Dr. Vernino discusses the relationship between autoimmunity and autonomic failure.
POTS is a mind-body disorder. Neurotransmitters such as norepinephrine, dopamine, adrenaline, serotonin and acetylcholine, which help the nervous system to work, are often released abnormally in patients with POTS and can affect the mental state of the POTS patient.
Some links and features may not work immediately. All links and features will be actively working in the next 24-72 hours. Thank you for your patience.
The Dysautonomia Project book has reached around the world as a much-needed tool for providers, patients or caregivers looking to arm themselves with the power of knowledge.
